Jeff Castelli insider trades
Open-market stock purchases and sales by Jeff Castelli, Chief Development Officer at Amicus Therapeutics, Inc, from SEC Form 4 filings since Jun 18, 2013.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +110%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $6.2M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $830K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.3M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.5M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.4M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.4M |
| Jan 3, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $330K |
| Jan 2, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $98.5K |
| Nov 24, 2025 | FOLD Amicus Therapeutics, Inc | Sold | $774K |
| Nov 24, 2025 | FOLD Amicus Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- FOLD Amicus Therapeutics, Inc: 3 buys, 13 sales, last Apr 27, 2026